Developing the “Healthcare CEO App” for Patients with Type 1 Diabetes Transitioning from Adolescence to Young Adulthood: A Mixed-Methods Study (Preprint)

Author:

Chiang Yueh-TaoORCID,Chang Chi-Wen,Yu Hsing-Yi,Tsay Pei-Kwei,Lo Fu-Sung,Chen Chi-Wen,Lin Wen-Yen,Hsu Chien-Lung,Moons Philip

Abstract

BACKGROUND

Adolescents with type 1 diabetes face various challenges which are often associated with poor blood glucose control during their transition to early adulthood. Using appropriate mobile applications for health management can improve the efficiency of disease self-management.

OBJECTIVE

To develop and test a mobile application that supports the disease self-management of adolescents with type 1 diabetes during their transition to early adulthood.

METHODS

A sequential mixed-methods design was employed. The application content was designed according to previously identified care needs and expectations, followed by application development on the Android operating system. From the outpatient clinic of the Department of Pediatric Endocrinology and Metabolism at a medical center in northern Taiwan, 35 individuals aged between 16 and 25 years participated in application testing.

RESULTS

The final application consisted of 11 interfaces, namely: CEO’s Profile, Health Tracking, CEO Knowledge Base, Barrier-free Communication, See Here: Diet and Exercise, Help Me, Detective!, CEO Chat Room, CEO's Secretary, SOS Calls, Q & A, and Who’s the Best CEO . The average user interaction satisfaction score of the application was 4.54 (± 0.41), indicating positive interaction satisfaction.

CONCLUSIONS

In this study, we developed the Healthcare Chief Executive Officer application tailored to the needs of patients with type 1 diabetes in the transition period. The application can support the disease self-management of adolescents with type 1 diabetes in the transition period, as well as provide references for clinical intervention.

CLINICALTRIAL

Future research will use a randomized controlled trial (RCT) design to evaluate the effectiveness of the application. Trial registration: listed on ClinicalTrials.gov, identifier: NCT05022875.

Publisher

JMIR Publications Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3